Midday movers: Nvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall

UnitedHealth Group (UNH) PT Raised to $632 at Deutsche Bank

Deutsche Bank analyst George Hill raised the price target on UnitedHealth Group (NYSE: UNH) to $632.00 (from $562.00) while maintaining a Buy rating.

The analyst comments "Another Messy Quarter - UNH reported Q2 earnings that delivered a modest EPS beat vs the Street, but with the... More

Needham Out Defending TSM (TSM): 'buyers on the weakness'

Needham analyst Charles Shi reiterated a Buy rating and $210.00 price target on Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE: TSM)

The analyst comments "

Following our quick take note published earlier this morning, we are updating our TSMC model and making some small... More

Meta Platforms exploring stake in Ray-Ban maker EssilorLuxottica - reports

According to reports from the Financial Times and Wall Street Journal on Thursday, Facebook owner Meta Platforms (NASDAQ: META) is assessing a potential multibillion-euro investment in eyewear group EssilorLuxottica.

Citing people with knowledge of the matter, the WSJ said the social media platform is in talks to purchase around a 5% stake in the company as it strengthens its push to develop smart glasses.

However, it... More

Synchrony Financial (SYF) PT Raised to $55 at RBC Capital

RBC Capital analyst Jon Arfstrom raised the price target on Synchrony Financial (NYSE: SYF) to $55.00 (from $50.00) while maintaining a Sector Perform rating.

The analyst comments "We are recapping 2Q earnings. We see fundamentals as meeting our expectations and are encouraged that... More

RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)

RBC Capital analyst Shagun Singh reiterated an Outperform rating and $175.00 price target on Johnson & Johnson (NYSE: JNJ).

The analyst comments "JNJ's stock traded higher (+3.7%) post-Q2'24 beat. It maintained its FY24 adjusted operational sales growth outlook but lowered adjusted EPS to reflect M&A-related... More

Goldman Sachs Out Positive on Apple (AAPL), 'We expect AAPL to deliver an EPS beat'

Goldman Sachs analyst Michael Ng reiterated a Buy rating and $265.00 price target on Apple (NASDAQ: AAPL).

The analyst comments "We expect AAPL to deliver an EPS beat in F3Q24E with $85.1 bn of revenue (+4% yoy) and EPS of $1.36 (v. FactSet consensus $1.33). We... More

Microsoft (MSFT) PT Raised to $495 at TD Cowen

TD Cowen analyst J. Derrick Wood raised the price target on Microsoft (NASDAQ: MSFT) to $495.00 (from $470.00) while maintaining a Buy rating.

The analyst comments "Office 365 Commercial: We model 14% cc growth (vs. 15% cc last qtr) and expect MSFT to deliver an in-line qtr. While vendor consolidation and ARPU growth via... More

Synchrony Financial (SYF) PT Raised to $60 at Jefferies

Jefferies analyst John Hecht raised the price target on Synchrony Financial (NYSE: SYF) to $60.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "EPS of $1.55 beats cons on key line items (RSA, Provision, and OPEX). Credit continues its Y/Y improvement and fared... More

Deutsche Bank Downgrades Five Below (FIVE) to Hold

Deutsche Bank analyst Paul Trussell downgraded Five Below (NASDAQ: FIVE) from Buy to Hold with a price target of $79.00 (from $155.00).

The analyst comments "We are downgrading shares of FIVE to Hold with a $79 PT given heightened uncertainty around its margin outlook and earnings power. While shares have meaningfully... More

Synchrony Financial (SYF) PT Raised to $53 at JPMorgan

JPMorgan analyst Richard Shane raised the price target on Synchrony Financial (NYSE: SYF) to $53.00 (from $52.00) while maintaining a Neutral rating.

The analyst comments "We maintain our Neutral rating, while noting that the relative value story has improved. SYF appears cheap on both a... More

Johnson & Johnson (JNJ) PT Raised to $160 at Stifel

Stifel analyst Rick Wise raised the price target on Johnson & Johnson (NYSE: JNJ) to $160.00 (from $155.00) while maintaining a Hold rating.

The analyst comments "Offsetting concerns about China and competitive pressures, JNJs robust Innovative Medicine (65.5% of sales, +8.8% y/y) performance reiterated a still-positive 2H24 growth... More

CFRA Upgrades J.B. Hunt Transport Services (JBHT) to Hold

CFRA analyst Arun Sundaram upgraded J.B. Hunt Transport Services (NASDAQ: JBHT) from Sell to Hold with a price target of $174.00 (from $148.00).

The analyst comments "We lift our 12-month target price to $174 from $148, 23x our 2025 EPS of $7.55 (cut from $8.86; 2024 cut to $5.65 from $6.77) and in line with its... More

Wolfe Research Defending ASML Holding NV (ASML:NA) (ASML): 'our first reaction is to buy this morning's pullback'

Wolfe Research analyst Chris Caso reiterated an Outperform rating and EUR1,050.00 price target on ASML Holding NV (ASML:NA) (NASDAQ: ASML).

The analyst comments "ASML posted solid 2Q bookings and maintained full year CY24 guidance, which we think sets up for a strong 2H24 and CY 25. The stock is however down on the report, we think for two reasons. One is that 3Q rev guide came in slightly below consensus (7bn at... More